Information for Peptide: AENGPGPGVLVLR from IGF1R_HUMAN
1. Biological Peptide
1.1 Native Sequence
K.AENGPGPGVLVLR.A
1.2 Peptide Properties
| Start | Stop | MW | m/z for 2+ | m/z for 3+ | pI |
|---|---|---|---|---|---|
| 1325 | 1337 | 1277.71 | 639.86 | 426.91 | 6.05 |
1.3 Fragment Ion Table
| AA | b Ion Series | b Ion Mass | y Ion Series | y Ion Mass |
|---|---|---|---|---|
| A | b | y | ||
| E | b | y | ||
| N | b | y | ||
| G | b | y | ||
| P | b | y | ||
| G | b | y | ||
| P | b | y | ||
| G | b | y | ||
| V | b | y | ||
| L | b | y | ||
| V | b | y | ||
| L | b | y | ||
| R | b | y |
2. Synthetic Peptide
2.1 Synthetic (Internal Standard) Peptide Sequence
(NONE)
2.2 Peptide Properties
(NONE)
2.3 Fragment Ion Table
(NONE)
2.4 Peptide Synthesis Report
(NONE)
2.5 QqQ MS/MS
2.6 Calibration Curve of Standard
Description: NONE
Experiment Description: Cells from Melanoma cancer line WM3130 and colon cancer cell line HT29 were lysed in 8M urea/100mM Ammonium bicarbonate buffer. The equivalent of 200,000 cells were loaded onto an SDS gel.
2.7 LC-MRM Analysis of Biological and Standard Peptides Illustrates Elution Times
2.8 Pseudo MS/MS Comparison of Transition Patterns for Biological/Standard Peptides
